Surmodics, Inc. Share Price

Equities

SRDX

US8688731004

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
26.17 USD 0.00% Intraday chart for Surmodics, Inc. -1.21% -28.01%
Sales 2024 * 120M 9.58B Sales 2025 * 136M 10.9B Capitalization 373M 29.82B
Net income 2024 * -16M -1.28B Net income 2025 * 5M 400M EV / Sales 2024 * 3.11 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 2.74 x
P/E ratio 2024 *
-22.4 x
P/E ratio 2025 *
65.4 x
Employees 376
Yield 2024 *
-
Yield 2025 *
-
Free-Float 96.25%
More Fundamentals * Assessed data
Dynamic Chart
1 week-1.21%
Current month-10.80%
1 month-7.23%
3 months-23.81%
6 months-8.08%
Current year-28.01%
More quotes
1 week
25.22
Extreme 25.22
27.00
1 month
25.22
Extreme 25.22
29.78
Current year
25.22
Extreme 25.22
37.50
1 year
16.79
Extreme 16.79
39.41
3 years
16.00
Extreme 16
62.27
5 years
16.00
Extreme 16
62.27
10 years
16.00
Extreme 16
82.35
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 26/12/10
Director of Finance/CFO 57 31/01/07
Corporate Officer/Principal 55 31/10/18
Members of the board TitleAgeSince
Director/Board Member 77 16/02/14
Chairman 70 28/01/08
Director/Board Member 68 31/12/01
More insiders
Date Price Change Volume
26/04/24 26.17 0.00% 22,671
25/04/24 26.17 +0.38% 31,837
24/04/24 26.07 -3.16% 62,844
23/04/24 26.92 +6.03% 52,914
22/04/24 25.39 -4.15% 116,361

Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm

More quotes
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The Company's segments include Medical Device and IVD. The Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral, coronary and structural heart. It manufactures vascular intervention medical devices, including drug-coated balloons, and radial access balloon catheters and guide sheaths. The IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
26.17 USD
Average target price
59 USD
Spread / Average Target
+125.45%
Consensus